Headway, a New York-based digital behavioral health startup known for its teletherapy software, is reportedly preparing to secure a new $100 million investment from leading venture capital firms Spark Capital, Thrive Capital, Andreessen Horowitz, and Accel. Bloomberg News, citing sources “familiar with the matter,” reports that this infusion of capital would value Headway at more than $1 billion, making it the first digital behavioral health unicorn of 2023.
This milestone highlights the growing investor interest in technology-driven mental health solutions, even as overall digital behavioral health funding shows signs of slowing.
A Digital Platform Connecting Patients and Providers
Founded in 2017, Headway has built a platform designed to connect patients with mental health providers within their insurance networks. Patients can search for providers based on availability, treatment focus, demographics, and insurance coverage, helping to simplify what is often a complex and fragmented process.
In addition to supporting patients, Headway provides behavioral health providers with a suite of free technology tools, including teletherapy software, aimed at reducing administrative burdens. From appointment scheduling to insurance verification, Headway’s teletherapy software helps providers save time and focus on delivering care. The company’s business model is based on commissions from the insurance providers it partners with, rather than charging providers directly for access to its technology.
Funding History and Investor Confidence
Headway previously closed a $70 million Series B funding round in 2021, bringing its total funding to $100 million since its launch. The startup has not yet provided official comment regarding the new round, but if finalized, this latest investment will significantly expand Headway’s resources and market reach.
The investment comes at a time when digital behavioral health funding has experienced a slowdown. According to Rock Health, investors poured $2.1 billion into behavioral health companies in 2022—a 56% decline from the $4.8 billion invested in 2021. Despite this trend, Headway’s ability to attract top-tier venture capital signals strong confidence in its platform, business model, and growth trajectory.
Rapid Growth and Strategic Partnerships
Headway has quickly established partnerships with major health insurance payers, including Aetna, Anthem Blue Cross and Blue Shield, United, Cigna, Oscar, Oxford, and multiple regional Blue plans. In August, the company announced a partnership with CareFirst BlueCross BlueShield, allowing members to more easily find in-network behavioral health providers.
Headway’s teletherapy software has been a major differentiator, providing a user-friendly interface for both patients and providers. By integrating scheduling, insurance verification, and virtual sessions in one platform, Headway makes teletherapy software accessible for providers of all sizes.
Expanding Geographical Footprint and Leadership
In October, Headway expanded its services into California, marking its 15th state market. This geographic growth demonstrates the company’s ability to scale while navigating the regulatory and payer complexities of multiple state markets.
Headway has also strengthened its leadership team to support continued expansion. In January, Matt Hackett, former interim COO for digital events company Hopin, joined as chief strategy officer and head of product. Dr. Nicole Christian-Braithwaite was appointed as head of medical and clinical strategy, bringing clinical oversight to the company’s rapidly growing platform.
The Competitive Landscape
While Headway has gained significant investor attention, it is not the only company offering technology solutions for behavioral health providers. Alma, a startup focused on small mental health practices, provides teletherapy software along with automated billing and scheduling tools. Alma raised $130 million in August, bringing its total funding to more than $220 million. Both Headway and Alma illustrate the growing demand for teletherapy software and other digital tools that streamline operations for mental health providers, especially in a market where administrative burden is a major barrier to care.
By offering robust teletherapy software alongside administrative support, Headway ensures that behavioral health providers can manage virtual and in-person care efficiently, helping to expand access for patients across the country.
Looking Ahead
With its anticipated $100 million investment, Headway is poised to accelerate growth, expand into new markets, and enhance its teletherapy software for both patients and providers. The company’s dual focus on simplifying access to care and supporting providers operationally positions it uniquely in the digital behavioral health space.
As the first digital behavioral health unicorn of 2023, Headway’s rise reflects a broader shift in the industry: investors are betting on technology-driven solutions to address the nation’s mental health needs. For patients seeking timely access to care and providers seeking tools like teletherapy software to streamline operations, platforms like Headway are becoming essential.
With the backing of top-tier venture capital firms and a growing footprint across the United States, Headway appears well-positioned to continue shaping the digital behavioral health landscape for years to come.
